Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL

Nucleic Acids Research

Volumn 33, Issue 1, 2005, Pages 235-243

  Habu, Yuichiro ^a   Miyano Kurosaki, Naoko ^a   Kitano, Michiko ^a   Endo, Yumihiko ^a   Yukita, Masakazu ^a   Ohira, Shigeru ^a   Takaku, Hiroaki ^b   Nashimoto, Masayuki ^b   Takaku, Hiroshi ^a  

^a CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GUIDE RNA; MESSENGER RNA; RETROVIRUS VECTOR; RIBONUCLEASE; RNA PRECURSOR; TRANSFER RNA; 3' PRE TRNASE; 3'-PRE-TRNASE; GAG PROTEIN; METHIONINE TRANSFER RNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; ASSAY; CELL NUCLEUS; CELL STRAIN COS1; COMPLEX FORMATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; LEUKEMIA CELL LINE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RNA CLEAVAGE; RNA DEGRADATION; ANIMAL; CERCOPITHECUS; CHEMISTRY; GENE EXPRESSION; GENE VECTOR; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RETROVIRUS;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; ENDORIBONUCLEASES; GENE EXPRESSION; GENETIC VECTORS; HIV CORE PROTEIN P24; HIV-1; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; RETROVIRIDAE; RNA, GUIDE; RNA, TRANSFER, MET; RNA, VIRAL;

EID: 13744255355     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gki164     Document Type: Article

References (46)

1. Kelin,A.S., Klebba,C. and Hoelzer,D. (2000) Gene therapy of HIV-1 infection. In Unger,R.E., Kreuter,J. and Rubsaman-Waigmann,H. (eds.), Antivirals Agent AIDS. Marcel Dekker Inc., NY, 219-248.
2. Rigden,J.R., Ely,J.A., Macpherson,J.L., Gerlach,W.L., Sun,L.-Q. and Symonds,G.P. (1999) The use of ribozyme gene therapy for the inhibition of HIV replication and its pathogenic sequelae. In Rossi,J.J. and Couture,L.A. (eds.), Intracellular Ribozyme Applications, Principles and Protocols. Horizon Scientific Press, England, 93-102.
3. Dornburg,R. and Pomerantz,R.Z. (2000) Gene therapy and HIV-1 infection. In Templeton,N.S. and Lasic,D.D. (eds.), Gene Therapy, Therapeutic Mechanisms and Strategies. Marcel Dekker Inc., NY, 519-534.
4. Kurreck,J. (2003) Antisense technologies, improvement through novel chemical modifications. Eur. J. Biochem., 270, 1628-1644.
5. Jen,K.-Y and Gewirtz,A.M. (2000) Suppression gene expression by targeted disruption of messenger RNA available options and current strategies. Stem Cells, 18, 307-319.
6. Bunnell,B.A. and Morgan,R.H. (1998) Gene therapy for infectious diseases. Clin. Microbiol. Rev., 11, 42-56.
7. Martinez,M.A., Clotet,B. and Este,J. (2002) RNA interference of HIV replication. Trends Immunol., 23, 559-561.
8. Lori,F., Guallini,P., Gulluzzi,L. and Lisziewicz,J. (2002) Gene therapy approaches to HIV infections. Am. J. Pharmacogenomics, 2, 245-252.
9. Stevenson,M. (2003) Dissecting HIV-1 through RNA interference. Nature Rev. Immunol., 3, 851-858.
10. Scherer,L.J. and Rossi,J.J. (2003) Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol., 21, 1457-1465.
11. Takaku,H. (2004) Gene silencing of HIV-1 by RNA interference. Antivir. Chem. Chemother., 15, 57-65.
12. Yuan,Y., Hwang,E.S. and Altman,S. (1992) Targeted cleavage of mRNA by human RNase P. Proc. Natl Acad. Sci. USA, 89, 8006-8010.
13. Yuan,Y. and Altman,S. (1994) Selection of guide sequences that direct efficient cleavage of mRNA by human ribonuclease. Science 263, 1269-1273.
14. Guerrier-Takada,C., Li,Y. and Altman,S. (1995) Artificial regulation of gene expression in Escherichia coli by RNase P. Proc. Natl Acad. Sci. USA, 92, 11115-11119.
15. Hnatyszyn,H., Spruillm,G., Youngm,A., Seivrightm,R. and Kraus,G. (2001) Long-term RNase P-mediated inhibition of HIV-1 replication and pathogenesis. Gene Ther., 24, 1863-1871.
16. Kraus,G., Geffin,R., Spruill,G., Young,A.K., Seivright,R., Cardona,D., Burzawa,J. and Hnatyszyn,H.J. (2002) Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences. Proc. Natl Acad. Sci. USA, 99, 3406-3411.
17. Barnor,J.S., Endo,Y., Habu,Y., Miyano-Kurosaki,N., Kitano,M., Yamamoto,H. and Takaku,H. (2004) Effective inhibition of HIV-1 replication in cultured cells by external guide sequences and ribonuclease P. Bioorg. Med. Chem. Lett., 14, 4941-4944.
18. Nashimoto,M. (1997) Distribution of both lengths and 5′ terminal nucleotides of mammalian pre-tRNA 3′ trailers reflects properties of 3′ processing endoribonuclease. Nucleic Acids Res., 25, 1148-1154.
19. Takaku,H., Minagawa,A., Takagi,M. and Nashimoto,M. (2003) A candidate prostate cancer susceptibility gene encodes tRNA 3′ processing endoribonuclease. Nucleic Acids Res., 31, 2272-2278.
20. Takaku,H., Minagawa,A., Takagi,M. and Nashimoto,M. (2004) The N-terminal half domain of the long form of tRNase Z is required for the RNase 65 activity. Nucleic Acids Res., 32, 4429-4438.
21. Tavtigian,S.V., Simard,J., Teng,D.H., Abtin,V., Baumgard,M., Beck,A., Camp,N.J., Carillo,A.R., Chen,Y., Dayanantb,P. et al. (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nature Genet., 27, 172-180.
22. Minagawa,A., Takaku,H., Takagi,M. and Nashimoto,M. (2004) The missense mutations in the candidate prostate cancer gene ELAC2 do not alter enzymatic properties of its product. Cancer Lett., in press.
23. Nashimoto,M. (1995) Conversion of mammalian tRNA 3′ processing endoribonuclease to four-base-recognizing RNA cutters. Nucleic Acids Res., 23, 3642-3647.
24. Nashimoto,M. (1996) Specific cleavage of target RNAs from HIV-1 with 5′ half tRNA by mammalian tRNA 3′ processing endoribonuclease. RNA, 2, 523-534.
25. Nashimoto,M., Geary,S., Tamura,M. and Kaspar,R. (1998) RNA heptamers that direct RNA cleavage by mammalian tRNA 3′ processing endoribonuclease. Nucleic Acids Res., 26, 2565-2571.
26. Nashimoto,M. (2000) Anomalous RNA substrates for mammalian tRNA 3′ processing endoribonuclease. FEBS Lett., 472, 179-186.
27. Takaku,H., Minagawa,A., Takagi,M. and Nashimoto,M. (2004) A novel four-base-recognizing RNA cutter that can remove the single 3′ terminal nucleotides from RNA molecules. Nucleic Acids Res., 32 e91.
28. Tamura,M., Nashimoto,C., Miyake,N., Daikuhara,Y., Ochi,K. and Nashimoto,M. (2003) Intracellular mRNA cleavage by 3′ tRNase under the direction of 2′-O-methyl RNA heptamers. Nucleic Acids Res., 31, 4354-4360.
29. Cormack,B.P., Valdivia,R.H. and Falkow,S. (1996) FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173, 33-38.
30. Yang,T.T., Cheng,L. and Kain,S.R. (1996) Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res., 24, 4592-4593.
31. Miller,A.D. and Rosman,G.J. (1989) Improved retroviral vectors for gene transfer. BioTechniques, 7, 980-987.
32. Akkina,R.K., Walton,R.M., Chen,M.L., Li,Q.-X., Planelles,V. and Chen,I.Y. (1996) High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol., 70, 2581-2585.
33. Landau,N.R. and Littman,D.R. (1992) Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol., 66, 5110-5113.
34. + cells by a vesicular stomach virus protein G (VSV-G) pseudotyped HIV-1 vector. Stable gene expression in progeny cells, including dendritic cells. J. Hum. Virol., 1 346-352.
35. Burns,J.C., Friedmann,T., Driever,W., Burrascano,M. and Yee,J.-K. (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells. Proc. Natl Acad. Sci. USA, 90, 8033-8037.
36. Yee,J.K., Miyanohara,A., Laforte,P., Bouic,K., Burns,J.C. and Friedman,T. (1994) A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl Acad. Sci. USA, 91, 9564-9568.
37. Sakai,A., Hirabayasi,Y., Aizawa,S., Tanaka,M., Ida,S. and Oka,S. (1999) Investigation of a new p24 antigen detection system by the chemiluminescence-enzyme-immunoassay. J. Jap. Assoc. Infect. Dis., 73, 205-212.
38. Kuwasaki,T., Hosono,K., Takai,K., Ushijima,K., Nakashima,H., Saito,T., Yamamoto,N. and Takaku,H. (1996) Hairpin antisense oligonucleotides containing 2′-methoxynucleosides with base-pairing in the stem region at the 3′-end: penetration, localization, and anti-HIV activity. Biochem. Biophys. Res. Commun., 228, 623-631.
39. Clever,J., Mirandar,D.Jr and Parslow,T.G. (2002) RNA structure and packaging signals in the 5′ leader region of the human immunodeficiency virus type 1 genome. J. Virol., 76, 12381-12387.
40. McBride,M.S. and Panganiban,A.T. (1997) Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo. J. Virol., 71, 2050-2058.
41. Sullenger,B.A., Gallardo,H.F., Ungers,G.E. and Gilboa,E. (1990) Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell, 63, 601-608.
42. Sullenger,B.A., Lee,T.C., Smith,C.A., Ungers,G.E. and Gilboa,E. (1990) Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol. Cell. Biol., 10, 6512-6523.
43. Zhang,Y.A., Nemunaitis,J., Scanlon,K.J. and Tong,A.W. (2000) Anti-tumorigenic effect of K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice. Gene Ther., 7, 2041-2050.
44. Habu,Y., Miyano-Kurosaki,N., Nagawa,T., Matsumoto,N., Takeuchi,H. and Takaku,H. (2002) Inhibition of HIV-1 replication by an HIV-1 dependent ribozyme expression vector with the Cre/loxP (ON/OFF) system. Antivir. Chem. Chemother., 13, 273-281.
45. Mulligan,R.C. (1993) The science of gene therapy. Science 260, 926-932.
46. Miller,A.D. and Rosman,G.J. (1989) Improved retroviral vectors for gene transfer. BioTechniques, 7, 980-987.